Relationship of glycemic control and diabetes duration with fibromyalgia in patients with type 2 diabetes mellitus

Abstract

Aim: Fibromyalgia (FM) is a syndrome characterized by chronic widespread musculoskeletal pain, presence of specific tender points and other somatic symptoms. The objective of the present study was to identify the association of glycemic control and diabetes duration with FM based on 2016 American College of Rheumatology (ACR) criteria in patients with type 2 diabetes mellitus (T2DM).

Methods: A total of 275 consecutive patients with T2DM admitted to a university hospital setting were included in this cross-sectional study. FM was diagnosed based on ACR 2016 criteria in all patients. Age, gender, diabetes duration, and body mass index (BMI) were recorded and metabolic parameters were determined in all participants.

Results: HbA1c and fasting blood glucose were not significantly different between patients with FM and without FM. Diabetes duration was independently associated with FM in patients with T2 DM.

Conclusions: Development of FM in patients with T2DM was not associated with glycemic control but associated with diabetes duration. Clinicians should be aware of the possibility of concomitant FM in long term diabetes patients complaining of pain, fatigue and cognitive symptoms because of its devastating effect on quality of life.